Search Results | MSF Science Portal

Journal Article

|

Research

Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, et al.

2024-02-01 • Lancet Respiratory Medicine

BACKGROUND
Around 500,000 people worldwide develop rifampicin-resistant tuberculosis each year. The proportion of successful treatment outcomes remains low and new treatments are nee...

Journal Article

|

Research

du Cros PAK, Greig J, Cross GB, Cousins C, Berry C, et al.

2023-12-01 • International Journal of Tuberculosis and Lung Disease

BACKGROUND
The value, speed of completion and robustness of the evidence generated by TB treatment trials could be improved by implementing standards for best practice.

METH...

Journal Article

|

Research

Rekart ML, Mun L, Aung A, Gomez D, Mulanda WK, et al.

2023-01-09 • Microbiology Spectrum

We report the findings of a prospective laboratory diagnostic accuracy study to evaluate the sensitivity, specificity, and predictive values of the Xpert MTB/RIF Ultra assay for Mycobact...

MSF Ethics Review Board

|

Standardized survey templates

Gerstl S, Grandesso F, Siddiqui R, Greig J, du Cros PAK, et al.

2022-10-25

Ce modèle doit être utilisé comme cadre pour écrire votre protocole d'enquête de mortalité contextualisée. Il a été pré-approuvé par le comité de révision éthique de MSF le 12 juillet 20...

MSF Ethics Review Board

|

Standardized survey templates

Grandesso F, Gerstl S, Siddiqui R, Greig J, du Cros PAK, et al.

2022-10-25

Mortality Survey Protocol - standardised, MSF ERB approved, intersectional

This collection of files includes an overview of the whole process of conducting a mortality survey an...

Journal Article

|

Letter

Bastard M, Bonnet MMB, du Cros PAK, Khamraev AK, Hayrapetyan A, et al.

2015-02-01 • American Journal of Respiratory and Critical Care Medicine

Journal Article

|

Commentary

O'Brien DP, Ford NP, Vitoria M, Asiedu K, Calmy A, et al.

2015-11-12 • PLOS Neglected Tropical Diseases

MSF Ethics Review Board

|

Standardized survey templates

Gerstl S, Siddiqui R, Greig J, Lenglet AD, du Cros PAK, et al.

2017-08-24

Vaccination coverage survey protocol - standardised, MSF ERB approved, intersectional

This collection of files includes an overview of the whole process of conducting a vaccinat...

Journal Article

|

Research

Swaminathan A, du Cros PAK, Seddon JA, Mirgayosieva S, Asladdin R, et al.

2017-06-12 • BMC Infectious Diseases

Extensively drug-resistant (XDR) tuberculosis (TB) and multidrug resistant (MDR)-TB with additional resistance to injectable agents or fluoroquinolones are challenging to treat due to la...

Journal Article

|

Research

Horter SCB, Stringer B, Venis S, du Cros PAK

2014-09-24 • PLOS One

In 2011, Médecins Sans Frontières (MSF) established a blogging project, "TB&Me," to enable patients with multidrug-resistant tuberculosis (MDR-TB) to share their experiences. By Septembe...

Journal Article

|

Research

Rao VB, Johari N, du Cros PAK, Messina J, Ford NP, et al.

2015-05-05 • Lancet Infectious Diseases

An estimated 150 million people worldwide are infected with hepatitis C virus (HCV). HIV co-infection accelerates the progression of HCV and represents a major public health challenge. W...

Journal Article

|

Commentary

Ford NP, Singh K, Cooke GS, Mills EJ, von Schoen-Angerer T, et al.

2012-03-19 • Clinical Infectious Diseases

Research & Publication Guidance

|

Guidelines/How-Tos

McConnell R, Roll S, van der Kam S, Shanks L, Venis S, et al.

2012-02-01

Journal Article

|

Research

Abidi S, Achar J, Assao Neino MM, Bang D, Benedetti A, et al.

2020-03-20 • European Respiratory Journal

We sought to compare the effectiveness of two World Health Organization (WHO)-recommended regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB): a sta...

Journal Article

|

Commentary

Majumdar S, O'Brien DP, Hurtado N, Hewison CCH, du Cros PAK

2011-12-08 • Internal Medicine Journal

Journal Article

|

Research

Swaminathan A, du Cros PAK, Achar J, Kliescikova J, Mirgayosieva S, et al.

2020-04-22 • BMC Infectious Diseases

Background: There are unique challenges in the diagnosis and management of multi drug resistant tuberculosis (MDR-TB) in children. It is difficult to obtain confirmatory microbiological ...

Conference Material

|

Abstract

Truelove SA, Hedge S, Kostandova N, Niehaus L, Rao B, et al.

2021-05-18 • MSF Scientific Days International 2021: Research

INTRODUCTION
Since the emergence of the COVID-19 pandemic, concerns have arisen regarding the potential impact of outbreaks affecting Rohingya refugees living in the Kutupalong-Baluk...

Journal Article

|

Commentary

Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, et al.

2013-08-05 • Journal of Viral Hepatitis

Journal Article

|

Research

Bastard M, Sanchez-Padilla E, du Cros PAK, Khamraev AK, Parpieva N, et al.

2018-03-08 • PLOS One

The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic represent a serious threat for reducing the global burden of TB. Although data on HIV-negative DR-TB t...

Journal Article

|

Research

Stringer B, Lowton K, Tillashaikhov M, Parpieva N, Ulmasova D, et al.

2016-08-01 • International Journal of Tuberculosis and Lung Disease

SETTING
The joint Médecins Sans Frontières/Ministry of Health Multidrug-Resistant Tuberculosis (MDR-TB) Programme, Karakalpakstan, Uzbekistan.

OBJECTIVE
Uzbekistan has h...

Science Portal

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

Standards for clinical trials for treating TB

Detection of Mycobacterium tuberculosis complex using the Xpert MTB/RIF Ultra assay on the stool of pediatric patients in Dushanbe, Tajikistan

MSF ERB Enquête rétrospective sur la mortalité

Standardised mortality surveys

Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?

Generating evidence to improve the response to neglected diseases: how operational research in a Médecins Sans Frontières Buruli ulcer treatment programme informed international management guidance

Standardised vaccination coverage surveys

Peripheral Neuropathy in a Diabetic Child Treated with Linezolid for Multidrug-Resistant Tuberculosis: A Case Report and Review of the Literature

"I Can Also Serve as an Inspiration": A Qualitative Study of the TB&Me Blogging Experience and Its Role in MDR-TB Treatment

Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis

Expanding access to treatment for hepatitis C in resource-limited settings: Lessons from HIV/AIDS

Randomised controlled trials: how to do them in MSF

Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

The 'frozen state' of drug-resistant tuberculosis: notes from the field in Abkhazia

A case report of a child with probable drug resistant tuberculous pericarditis with a review of challenges involved in diagnosis, treatment and follow up of children with DR-TB pericarditis

Estimation of SARS-CoV-2 infections and deaths among Rohingya refugees, Kutupalong-Balukhali camps, Bangladesh

Viral hepatitis and the global burden of disease: a need to regroup

Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

'They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan